Skip to main content
Log in

Diagnostic Value of Kisspeptin Levels on Early Pregnancy Outcome: a Systematic Review and Meta-analysis

  • Review
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

The objective of this study is to investigate whether kisspeptin levels in early pregnancy have a better diagnostic value on early pregnancy outcome as compared with human chorionic gonadotropin (hCG). This study was a systematic review and meta-analysis aiming to investigate the diagnostic value of kisspeptin levels on early pregnancy outcome. The primary outcome was miscarriage or viable intrauterine pregnancy. Five studies were included for systematic review, and three studies were included for meta-analysis. Meta-analysis showed kisspeptin levels had a good diagnostic value with the area under the curve (AUC) 0.902 (0.866, 0.937) when kisspeptin was measured after 6 weeks of gestation. Sensitivity analysis demonstrated kisspeptin levels had a diagnostic value with AUC = 0.881 (0.855, 0.906). hCG levels had a diagnostic value with AUC = 0.834 (0.785, 0.883), which was inferior to the diagnostic value of kisspeptin (mean difference = 0.09 (0.02, 0.16)). Kisspeptin measurement has a potential for comparable or even higher accuracy than hCG in differentiating between miscarriage and viable intrauterine pregnancy after 6 weeks of gestation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

Availability of Data and Materials

All data generated or analysed during this study are included in this published article.

Abbreviations

AUC:

Area under the curve

hCG:

Human chorionic gonadotropin

CIs:

Confidence intervals

SE:

Standard error

sROC:

Summary receiver operating characteristic

RIA:

Radioimmunoassay

ELISA:

Enzyme-linked immunosorbent assay

References

  1. Savitz DA, Hertz-Picciotto I, Poole C, Olshan AF. Epidemiologic measures of the course and outcome of pregnancy. Epidemiol Rev. 2002;24(2):91–101.

    Article  Google Scholar 

  2. National Collaborating Centre for Ws, Children's H. National Institute for Health and Clinical Excellence: Guidance. Ectopic pregnancy and miscarriage: diagnosis and initial management in early pregnancy of ectopic pregnancy and miscarriage. London: Rcog National Collaborating Centre for Women's and Children's Health; 2012.

    Google Scholar 

  3. Jurkovic D, Overton C, Bender-Atik R. Diagnosis and management of first trimester miscarriage. Bmj. 2013;346:f3676.

    Article  Google Scholar 

  4. Larsen EC, Christiansen OB, Kolte AM, Macklon N. New insights into mechanisms behind miscarriage. BMC Med. 2013;11:154.

    Article  Google Scholar 

  5. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319(4):189–94.

    Article  CAS  Google Scholar 

  6. Farren J, Mitchell-Jones N, Verbakel JY, Timmerman D, Jalmbrant M, Bourne T. The psychological impact of early pregnancy loss. Hum Reprod Update. 2018;24(6):731–49.

    Article  Google Scholar 

  7. Lok IH, Neugebauer R. Psychological morbidity following miscarriage. Best Pract Res Clin Obstet Gynaecol. 2007;21(2):229–47.

    Article  Google Scholar 

  8. Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD, Fisher J, et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet (London, England). 2021;397(10285):1658–67.

    Article  CAS  Google Scholar 

  9. Wieringa-de Waard M, Bonsel GJ, Ankum WM, Vos J, Bindels PJ. Threatened miscarriage in general practice: diagnostic value of history taking and physical examination. Br J Gen Pract. 2002;52(483):825–9.

    Google Scholar 

  10. Preisler J, Kopeika J, Ismail L, Vathanan V, Farren J, Abdallah Y, et al. Defining safe criteria to diagnose miscarriage: prospective observational multicentre study. Bmj. 2015;351:h4579.

    Article  Google Scholar 

  11. West A, Vojta PJ, Welch DR, Weissman BE. Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1). Genomics. 1998;54(1):145–8.

    Article  CAS  Google Scholar 

  12. Hu KL, Chang HM, Zhao HC, Yu Y, Li R, Qiao J. Potential roles for the kisspeptin/kisspeptin receptor system in implantation and placentation. Hum Reprod Update. 2019;25(3):326–43.

    Article  CAS  Google Scholar 

  13. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 1996;88(23):1731–7.

    Article  CAS  Google Scholar 

  14. Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev. 2012;92(3):1235–316.

    Article  CAS  Google Scholar 

  15. Skorupskaite K, George JT, Anderson RA. The kisspeptin-GnRH pathway in human reproductive health and disease. Hum Reprod Update. 2014;20(4):485–500.

    Article  CAS  Google Scholar 

  16. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 2001;411(6837):613–7.

    Article  CAS  Google Scholar 

  17. Lee DK, Nguyen T, O'Neill GP, Cheng R, Liu Y, Howard AD, et al. Discovery of a receptor related to the galanin receptors. FEBS Lett. 1999;446(1):103–7.

    Article  CAS  Google Scholar 

  18. Kotani M, Detheux M, Vandenbbogaerde A, Communi D, Vanderwinden JM, Le Poul E, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001;276(37):34631–6.

    Article  CAS  Google Scholar 

  19. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem. 2001;276(31):28969–75.

    Article  CAS  Google Scholar 

  20. Hu KL, Zhao H, Yu Y, Li R. Kisspeptin as a potential biomarker throughout pregnancy. Eur J Obstet Gynecol Reprod Biol. 2019;240:261–6.

    Article  CAS  Google Scholar 

  21. Abbara A, Al-Memar M, Phylactou M, Kyriacou C, Eng PC, Nadir R et al (2021) Performance of plasma kisspeptin as a biomarker for miscarriage improves with gestational age during the first trimester. Fertil Steril

  22. Sullivan-Pyke C, Haisenleder DJ, Senapati S, Nicolais O, Eisenberg E, Sammel MD, et al. Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy. Fertil Steril. 2018;109(1):137–41.e2.

    Article  CAS  Google Scholar 

  23. Jayasena CN, Abbara A, Izzi-Engbeaya C, Comninos AN, Harvey RA, Gonzalez Maffe J, et al. Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage. J Clin Endocrinol Metab. 2014;99(12):E2652–60.

    Article  CAS  Google Scholar 

  24. Hu KL, Zhang Y, Yang Z, Zhao H, Xu H, Yu Y, et al. Predictive value of serum kisspeptin concentration at 14 and 21 days after frozen-thawed embryo transfer. Reprod BioMed Online. 2019;39(1):161–7.

    Article  CAS  Google Scholar 

  25. Yu H, Liu J, Guo H, Chen C, Han Y, Cui Y. Prognostic value of repeated serum kisspeptin measurements in early first trimester pregnancy: a preliminary study. Reprod BioMed Online. 2019;38(3):465–71.

    Article  CAS  Google Scholar 

  26. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36.

    Article  Google Scholar 

  27. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003;100(19):10972–6.

    Article  Google Scholar 

  28. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349(17):1614–27.

    Article  CAS  Google Scholar 

  29. Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab. 2003;88(2):914–9.

    Article  CAS  Google Scholar 

  30. Okamoto SH, Healy DL, Morrow LM, Rogers PA, Trounson AO, Wood EC. Predictive value of plasma human chorionic gonadotrophin beta subunit in diagnosing ectopic pregnancy after in vitro fertilisation and embryo transfer. Br Med J (Clin Res Ed). 1987;294(6573):667–70.

    Article  CAS  Google Scholar 

  31. Yamashita T, Okamoto S, Thomas A, MacLachlan V, Healy DL. Predicting pregnancy outcome after in vitro fertilization and embryo transfer using estradiol, progesterone, and human chorionic gonadotropin beta-subunit. Fertil Steril. 1989;51(2):304–9.

    Article  CAS  Google Scholar 

  32. Porat S, Savchev S, Bdolah Y, Hurwitz A, Haimov-Kochman R. Early serum beta-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term pregnancy outcome. Fertil Steril. 2007;88(1):82–9.

    Article  CAS  Google Scholar 

  33. Poikkeus P, Hiilesmaa V, Tiitinen A. Serum HCG 12 days after embryo transfer in predicting pregnancy outcome. Hum Reprod (Oxford, England). 2002;17(7):1901–5.

    Article  CAS  Google Scholar 

  34. Chi H, Qiao J, Li H, Liu P, Ma C. Double measurements of serum HCG concentration and its ratio may predict IVF outcome. Reprod BioMed Online. 2010;20(4):504–9.

    Article  CAS  Google Scholar 

  35. Savaris RF. Kisspeptin as a biomarker for miscarriage: let’s wait! Fertil Steril. 2018;109(1):67.

    Article  Google Scholar 

  36. Gude NM, Roberts CT, Kalionis B, King RG. Growth and function of the normal human placenta. Thromb Res. 2004;114(5-6):397–407.

    Article  CAS  Google Scholar 

  37. Ramachandran R, Patterson M, Murphy KG, Dhillo WS, Patel S, Kazarian A, et al. Preanalytical factors affecting RIA measurement of plasma kisspeptin. Clin Chem. 2008;54(3):615–7.

    Article  CAS  Google Scholar 

  38. Li R, Hu KL. Kisspeptin, a promising biomarker for miscarriage in early pregnancy. Fertil Steril. 2021;116(3):672–3.

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by grants from National Natural Science Foundation of China (81873835 and 82071726).

Author information

Authors and Affiliations

Authors

Contributions

KL.H conceived the idea; KL.H and Z.C reviewed the literature and extracted the data; KL.H, X.L and W.D assessed the quality of included studies; KL.H designed the study and wrote the manuscript and designed the figures and tables; H.Z and L.M and H.Y revised the manuscript. All authors participated in the discussion of the analysis and interpretation of data in this article.

Corresponding authors

Correspondence to Hong Zhang or Liangshan Mu.

Ethics declarations

Ethics Approval and Consent to Participate

Not applicable.

Consent for Publication

All authors approved the final version of the manuscript and consent for publication.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, KL., Chen, Z., Deng, W. et al. Diagnostic Value of Kisspeptin Levels on Early Pregnancy Outcome: a Systematic Review and Meta-analysis. Reprod. Sci. 29, 3365–3372 (2022). https://doi.org/10.1007/s43032-022-00856-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43032-022-00856-8

Keywords

Navigation